BCLSI
HTFL

Bain Capital Life Sciences Investors’s Heartflow Inc HTFL Stock Holding History

Bain Capital Life Sciences Investors’s Portfolio HTFL Stock Details HTFL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248M Sell
8,448,158
-2,000,000
-19% -$60.1M 14.74% 2
2026
Q1 		$254M Sell
10,448,158
-2,000,000
-16% -$54.3M 22.93% 1
2025
Q4 		$363M Hold
12,448,158
– – 27.79% 1
2025
Q3 		$419M Buy
+12,448,158
New +$400M 27.81% 1

Other funds holding HTFL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

Bain Capital Life Sciences Investors's HTFL Position: Q2 2026 in Review

Bain Capital Life Sciences Investors reduced its Heartflow Inc (HTFL) stake by 19% in Q2 2026, selling an estimated $60.1M and leaving 8,448,158 shares worth $248M. The position accounts for 14.74% of the portfolio, ranked #2.

Bain Capital Life Sciences Investors first reported a position in HTFL in Q3 2025 and has held it in 4 quarters since. The position peaked at $419M in Q3 2025. 193 funds tracked by Wall St. Rank hold HTFL as of Q2 2026.

  • Bain Capital Life Sciences Investors held 8,448,158 shares of Heartflow Inc worth $248M as of Q2 2026.
  • Bain Capital Life Sciences Investors sold 2,000,000 Heartflow Inc shares in Q2 2026, an estimated $60.1M.
  • Heartflow Inc made up 14.74% of Bain Capital Life Sciences Investors's portfolio in Q2 2026, its #2 holding.
  • Bain Capital Life Sciences Investors first reported a position in Heartflow Inc in Q3 2025 and has held it in 4 quarters since.
  • Bain Capital Life Sciences Investors's Heartflow Inc position peaked at $419M in Q3 2025.
  • 193 funds tracked by Wall St. Rank held Heartflow Inc as of Q2 2026.

Based on Bain Capital Life Sciences Investors's 13F filing for Q2 2026, filed 14 Aug 2026.